3 Pharma Stocks Too Cheap to Ignore
StockNews
Published Nov 29, 2021 05:05PM ET
Updated Nov 29, 2021 06:31PM ET
3 Pharma Stocks Too Cheap to Ignore
As a new COVID-19 variant (omnicron) raises concerns worldwide, we think it could be wise to scoop up the shares of quality pharmaceutical stocks GlaxoSmithKline (NYSE:GSK), Teva Pharmaceutical (TEVA), and Eagle Pharmaceuticals (NASDAQ:EGRX) that look undervalued at their current price levels. These stocks each has an overall A (Strong Buy) or B (Buy) rating in our POWR Ratings system and an A grade for Value. Read on.Pharma stocks are once again at the fore, with fresh concerns over the new omicron COVID-19 variant. On November 21, 2021, Dr. Anthony Fauci warned that time was running short to prevent a “dangerous” resurgence of COVID-19 infections during the upcoming holiday season. His statements are deemed to have piqued investor interest in the pharma sector, as evidenced by the iShares U.S. Pharmaceuticals ETF’s (IHE) 2.5% returns over the past month.
In addition, with surging chronic diseases around the globe, the pharmaceuticals sector is expected to grow significantly. According to a Markets and Markets report, the global pharmaceutical drug delivery market is expected to reach $2.21 trillion by 2026, growing at a 5.9% CAGR.
Therefore, we think it could be wise to add fundamentally sound yet undervalued pharmaceutical stocks GlaxoSmithKline plc (GSK), Teva Pharmaceutical Industries Limited (NYSE:TEVA), and Eagle Pharmaceuticals, Inc. (EGRX) to one’s portfolio now. These stocks have an overall A (Strong Buy) or B (Buy) grade in our POWR Ratings system. They also have an A grade for Value.
Continue reading on StockNews
Get The News You Want
Written By: StockNews
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.